NClip

Cardiogenic Shock

3 min read

Cardiogenic Shock

Key Points

  • Cardiogenic shock is life-threatening pump failure with severe hypotension and systemic hypoperfusion.
  • Large myocardial infarction is a common trigger, but other cardiac disorders can also cause this phenotype.
  • Reduced contractility lowers stroke volume and cardiac output, while blood backs up into the lungs and worsens oxygenation.
  • ICU care focuses on cause-directed treatment, vasoactive titration, and invasive support with close complication surveillance.

Pathophysiology

Cardiogenic shock develops when myocardial injury causes the heart to lose effective pumping strength. Decreased contractility reduces stroke volume and cardiac output, so forward perfusion drops and tissue hypoxia progresses.

As forward flow falls, pressure backs up into the pulmonary circulation, increasing congestion and hypoxia risk. Early compensatory tachycardia may briefly support output, but persistent workload stress can accelerate decompensation and multiorgan dysfunction.

Common Causes

  • Large myocardial infarction with extensive ventricular injury
  • Acute decompensated heart-failure pathways with severe low-output physiology
  • Other high-severity cardiac disorders that impair ventricular contractile performance

Clinical Manifestations

  • Hypotension and worsening perfusion signs
  • Tachycardia with progressive hemodynamic instability
  • Shortness of breath and pulmonary crackles
  • Diaphoresis and cool clammy skin trend
  • S3 heart sound in low-output congestion contexts
  • Hypoxia and reduced end-organ perfusion

Nursing Assessment

  • Perform frequent cardiovascular reassessment to detect subtle baseline-to-trend changes.
  • Combine bedside findings (heart sounds, pulses, capillary refill, respiratory status) with invasive hemodynamic trends.
  • Track cardiac output and stroke-volume profile in the context of blood-pressure trajectory.
  • Use serial cardiac index and central-venous-pressure trends to identify worsening low-output status.
  • Escalate rapidly for falling blood pressure, declining oxygenation, or signs of evolving multiorgan hypoperfusion.

Nursing Interventions

  • Support immediate cause-directed treatment and perfusion stabilization per protocol and provider orders.
  • Administer and titrate ordered vasoactive infusions with strict hemodynamic reassessment and standing-order adherence.
  • Prepare and maintain invasive support (for example IABP or ECMO) when pharmacologic support is insufficient.
  • Monitor high-risk complications of invasive support: bleeding, thromboembolism, infection, and limb ischemia.
  • Coordinate interdisciplinary care with critical-care, cardiology, and perfusion teams when advanced support is used.

Evaluation Targets

  • Systolic blood pressure and MAP improve toward ordered perfusion goals.
  • Cardiac index trends upward and low-output signs decrease.
  • Oxygenation and pulmonary congestion markers stabilize.
  • Urine output and mental-status trends indicate improving end-organ perfusion.

Clinical Judgment Application

Clinical Scenario

A CICU patient with biventricular-failure signs has BP trend decline from 90/52 to 82/52 mmHg, cardiac-index decline from about 2-3 to 1-1.5 L/min, and rising CVP from 7 to 10 mmHg despite active infusion support.

  • Recognize Cues: Falling blood pressure and cardiac index with rising filling-pressure trend.
  • Analyze Cues: Pattern is worsening pump failure with inadequate forward perfusion.
  • Prioritize Hypotheses: Immediate threat is progression of cardiogenic shock with multiorgan risk.
  • Generate Solutions: Intensify hemodynamic surveillance and prepare escalation of vasoactive/mechanical support.
  • Take Action: Execute ordered titrations, reassess continuously, and escalate deterioration without delay.
  • Evaluate Outcomes: Perfusion markers stabilize and shock progression slows or reverses.

Self-Check

  1. Why can cardiogenic shock produce both pulmonary congestion and systemic hypoperfusion?
  2. Which trend pattern in BP, CI, and CVP suggests worsening low-output status?
  3. Which invasive-support complications require immediate bedside escalation?

Graph View